HIRD, A. E.; MAGEE, D. E.; CHEUNG, D. C.; MATTA, R.; KULKARNI, G. S.; NAM, R. K. Abiraterone vs. docetaxel for metastatic hormone-sensitive prostate cancer: A microsimulation model. Canadian Urological Association Journal, [S. l.], v. 14, n. 9, p. E418–27, 2020. DOI: 10.5489/cuaj.6234. Disponível em: https://cuaj.ca/index.php/journal/article/view/6234. Acesso em: 18 apr. 2024.